Inauguración de las Jornadas en #Inmunooncologia organizadas por el WorkModule de @CIBERONC CIBER ISCIII y con sede excelente en Josep Carreras Leukaemia Research Institute (IJC). ¡Arrancamos! 🧬🔬👩‍🔬

👏👏🧪🧪

Amazing work by Núria Eritja, Cris.Megino, Xavier Matias-Guiu G and colleagues! Congrats to all! @CIBERONC IRBLleida IDIBELL Bellvitge Pathology Hospital Universitari Bellvitge | HUB

Thiemo Fetzer 🇪🇺🇺🇦 - same handle elsewhere Federica Romei Xavier Jaravel @a_m_elsner Indeed, the ERC has sent letters to successful UK-based applicants for Starting, Consolidator and Advanced Grants giving them 2 month to decide if they move to an eligible host institution or give up the grant. We'll be ready to extend this time in exceptional, justified cases.

🗞 Publicado en The Lancet‼️ Una terapia triple demuestra importantes beneficios en el tratamiento del cáncer de próstata metastásico. ➕ bit.ly/AbirateroneVHI… #InvestigaciónClínica

cat_ Per acabar amb la campanya amb #FeSalut amb motiu del #DiaMundialSalut, des de l'IRBLleida treballem en benefici de la millora de la salut de totes les persones. Els 37 grups de recerca de l'#IRBLleida treballen en 5 àrees diferents d'investigació. #DiaMundialSalut #DMSalut

📌Not one, not two, but 3 positions available to work @CIBERONC CIBER ISCIII. Check them out, apply and/or share the word! 🩺ciberisciii.es/empleo/detalle… 🔬ciberisciii.es/empleo/detalle… 🔖ciberisciii.es/empleo/detalle…

Los números hablan por si solos. 👀 La Fundación FERO es una de las principales promotoras de la investigación oncológica traslacional en España. 💪 #StopCáncer

🔊🔊🔊🔊We have extended the application deadline for an additional week. Check these opportunities out and apply/share!!!

Our last study is out @AdvSciNews! “Generation and Integrated Analysis of Advanced Patient‐Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer”onlinelibrary.wiley.com/doi/10.1002/ad…

Tot a punt per explicar la campanya 'el Paper de la Ciència'

ESGO 2024 is here! The first workshops have started at the CCIB in beautiful Barcelona. Welcome! #ESGO2024

We are pleased to award the Helga Salvesen Award 🏆 for a major contribution in translational and clinical research to Xavier Matias-Guiu Guia. Congratulations! #ESGO2024 Xavier Matias-Guiu G

Xavier Matias-Guiu G “The daily work is very inspiring.” Prof Matias-Guiu Guia gave a talk on his career in pathology, following an introduction by Mansoor Mirza. #ESGO2024

Career highlights and ESP presidency, do not miss this interview with Xavier Matias Guiu! @CIBERONC CIBER ISCIII Peer-to-Peer: Ivan Damjanov Interviews Xavier Matias-Guiu thepathologist.com/issues/2025/ar…

Career highlights and ESP presidency European Society of Pathology (ESP) , do not miss this interview with Xavier Matias-Guiu G ! @CIBERONC CIBER ISCIII Peer-to-Peer: Ivan Damjanov Interviews Xavier Matias-Guiu thepathologist.com/issues/2025/ar…

🆕cat_ Investigadors de l'IRBLleida i l’I@idibell_cat identifiquen molècules clau en el càncer d’endometri    📷 Maria Vidal i Xavier Dolet irblleida.org/ca/noticies/19… #IRBLleida #biomedicalresearch

🆕eng_ The study reveal the role of an endometrial cluster (called miR-424(322)~503) in endometrial cancer.  nature.com/articles/s4141…

Personal investigador #CIBERONC identifica moléculas clave en la progresión del #cáncerdeendometrio 🔎 ⬇️

Researchers from IRBLleida, CIBER ISCIII and IDIBELL identify key molecules in the progression of endometrial cancer🔬 It represents another step towards designing treatments that can address diseases such as this cancer or endometriosis💪 👉 idibell.cat/en/2025/10/res…